The microbiome signatures in the context of gynecologic cancers (endometrial and ovarian) and the potential for their clinical use will be discussed. The use of microfluidic technologies to interrogate the role of these microbes in the disease processes and interference with treatment will also be addressed.
1. Learn how the vaginal microbiome can be used to detect endometrial cancer
2. Study ovarian cancer microbiome use as a prognostic tool
3. Explore the use of microfluidic technologies for a single cell level of mechanistic interrogation for the role of the microbiome in gynecologic cancers
Research And Development